Bank of Montreal’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Buy
32,308
+3,535
+12% +$243K ﹤0.01% 1664
2026
Q1
$1.84M Buy
28,773
+3,947
+16% +$274K ﹤0.01% 1707
2025
Q4
$1.97M Buy
24,826
+7,041
+40% +$595K ﹤0.01% 1656
2025
Q3
$1.18M Buy
17,785
+6,797
+62% +$404K ﹤0.01% 1895
2025
Q2
$582K Buy
10,988
+5,137
+88% +$241K ﹤0.01% 2193
2025
Q1
$290K Buy
+5,851
New +$325K ﹤0.01% 2531
2024
Q2
Sell
-6,453
Closed -$404K 4060
2024
Q1
$404K Buy
+6,453
New +$418K ﹤0.01% 2585
2022
Q3
Sell
-5,013
Closed -$276 4231
2022
Q2
$276 Buy
+5,013
New +$222K ﹤0.01% 3059

Other funds holding IRON

Bank of Montreal's IRON Position: Q2 2026 in Review

Bank of Montreal increased its Disc Medicine (IRON) stake by 12% in Q2 2026, buying an estimated $243K and bringing the position to 32,308 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Bank of Montreal first reported a position in IRON in Q2 2022 and has held it in 8 quarters since. 197 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Bank of Montreal held 32,308 shares of Disc Medicine worth $2.36M as of Q2 2026.
  • Bank of Montreal bought 3,535 Disc Medicine shares in Q2 2026, an estimated $243K.
  • Disc Medicine made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1664 holding.
  • Bank of Montreal first reported a position in Disc Medicine in Q2 2022 and has held it in 8 quarters since.
  • 197 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.